P2Y<sub>6</sub>R together with CYSLTR2 serves as endogenous receptor for long-chain ceramides in atherosclerosis. [PDF]
Ye Q, Tang Y.
europepmc +1 more source
Gap Junctional Versus Paracrine Signaling in the Human Lens Epithelium: Analysis Based on Multicellular Ca²⁺ Imaging and Computational Modeling. [PDF]
Šterk M +5 more
europepmc +1 more source
Macrophage P2Y<sub>6</sub> receptor signalling as a key mediator and therapeutic target in atherosclerosis. [PDF]
Collado A, Zhou Z.
europepmc +1 more source
Editorial-Translation of purinergic drugs into therapeutic use. [PDF]
Kennedy C.
europepmc +1 more source
Molecular mechanisms of acute inflammation: systemic responses and kidney-specific pathophysiology. [PDF]
Chelangarimiyandoab F +4 more
europepmc +1 more source
Glial Activation, Neuroinflammation, and Loss of Neuroprotection in Chronic Pain: Cellular Mechanisms and Emerging Therapeutic Strategies. [PDF]
McKenzie A +4 more
europepmc +1 more source
Damage-induced pyroptosis drives endogenous thymic regeneration by activating the purinergic receptor P2Y2. [PDF]
Kinsella S +13 more
europepmc +1 more source
Extracellular Vesicles and Purinergic Signaling in Alzheimer's Disease-Joining Forces for Novel Therapeutic Approach. [PDF]
Lewandowska J, Majewski J, Roszek K.
europepmc +1 more source
Targeting P2X Receptors-Current Progress in Sepsis. [PDF]
Luo L +5 more
europepmc +1 more source

